Age for Routine Administration of the Second Dose of Measles–Mumps–Rubella Vaccine

This publication has 19 references indexed in Scilit:

• Immunization of Adolescents: Recommendations of the Advisory Committee on Immunization Practices, the American Academy of Pediatrics, the American Academy of Family Physicians, and the American Medical Association
  Pediatrics, 1997
• Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at four to six vs. eleven to thirteen years
  The Pediatric Infectious Disease Journal, 1996
• Secondary failure rates of measles vaccines: a metaanalysis of published studies
  The Pediatric Infectious Disease Journal, 1996
• Cellular Immunity in Measles Vaccine Failure: Demonstration of Measles Antigen-Specific Lymphoproliferative Responses despite Limited Serum Antibody Production after Revaccination
  The Journal of Infectious Diseases, 1995
• Immunoglobulin M antibody response to measles virus following primary and secondary vaccination and natural virus infection
  Journal of Medical Virology, 1993
• Mumps outbreak in a highly vaccinated population
  The Journal of Pediatrics, 1991
• Measles Outbreak in a Fully Immunized Secondary-School Population
  New England Journal of Medicine, 1987
• Persistence of Vaccine-Induced Immune Responses to Rubella: Comparison with Natural Infection
  Clinical Infectious Diseases, 1985
• Additional evidence against measles vaccine administration to infants less than 12 months of age: Altered immune response following active/passive immunization
  The Journal of Pediatrics, 1979
• Persistence of maternal antibody in infants beyond 12 months: Mechanism of measles vaccine failure
  The Journal of Pediatrics, 1977